Navigation Links
PneumRx, Inc.'s RePneu Coil Becoming Therapy of Choice for Patients with Severe Emphysema
Date:9/26/2013

MOUNTAIN VIEW, Calif., Sept. 26, 2013 /PRNewswire/ -- PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil (LVRC) System for patients with severe emphysema.

(Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO)

The RePneu LVRC is a minimally invasive device intended to improve lung function, exercise capacity and quality of life in emphysema patients by bronchoscopically implanting Nitinol coils into the lung to compress diseased tissue, restore elastic recoil, and re-tension the airway network.  This treatment is a minimally invasive treatment that is effective for a broad range of emphysema patients.

The RePneu LVRC's impressive market adoption is evidenced by the fact that over 1500 RePneu LVRC treatments have been performed, involving over 15,000 Coils, even though the LVRC has been commercially available for just over 2 years.  In addition to being commercially available in Germany, Italy, Switzerland and Turkey, the RePneu LVRC was selected by the French Ministry of Health for, and is currently undergoing, a multi-center cost-effectiveness study in France (STIC), supported by the French Ministry of Health.  Over 75 subjects have been enrolled in the French study, the REVOLENS, since March 2013, and enrollment is expected to be completed, ahead of schedule, before the end of the year.

The RePneu LVRC is rapidly becoming the therapy of choice for emphysema patients in European markets because of its ability to treat a broad range of emphysema patients without requiring any complex diagnostic evaluation.  The RePneu Coil does not block airways, prevent distal access, or destro
'/>"/>

SOURCE PneumRx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PneumRx, Inc. Acquires Key Assets From Broncus
2. PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System
3. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
4. New Survey: Hispanic Teen Drug Use Significantly Higher Than Other Ethnic Groups, Substance Abuse Becoming Normalized Behavior Among Latino Youth
5. Engineering Talent Becoming Scarce Commodity; Organizations Struggling to Optimize Talent Pipelines
6. Employers Becoming Savvier About Biologics and Specialty Drugs
7. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
8. Laser-Proton Therapy Working Group Takes Second Look at Ways to Lower Cost of Advanced Cancer Treatment
9. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
10. Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer
11. Studies Show Excellent Outcomes With Strut-Based Breast Brachytherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... the following open letter to shareholders from President ... Sc. Dear RXi Shareholders, ... inaccurate statements posted on certain social media sites ...
(Date:12/22/2014)...  Pfenex Inc. (NYSE MKT: PFNX) today announced the ... filed and is now open and that this program ... Health and Human Services (HHS), through the Biomedical Advanced ... extremely pleased to have the IND now active for ... milestone in our company,s partnership with BARDA as we ...
(Date:12/19/2014)...  In the Friday, December 19 edition of ... Information Technology (HIT) features Konica Minolta, the company announced today. The ... several leading healthcare organizations. In addition to the ... such as New York , Chicago ... , Minneapolis and San Francisco ...
Breaking Medicine Technology:RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2
... 2010 Third Quarter Results -- HARBIN, China, Sept. 13 /PRNewswire-Asia-FirstCall/ -- ... ... ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... (Nasdaq: TSRX ) announced today that Jeffrey ... Therapeutics, will provide a corporate presentation to investors attending ... at 8:35 a.m. ET at the Four Seasons Hotel ... will be available through the Investor Relations page of ...
Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 3Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 4Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 5Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 6Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results 7
(Date:12/22/2014)... CA (PRWEB) December 22, 2014 The ... PALS, BLS and ACLS online certification provider, are proud ... http://www.acls-pals-bls.com . The updated site now features a more ... than ever to use. , As a company ... information is now consolidated into a single page during ...
(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
(Date:12/22/2014)... 22, 2014 Physicians in China are ... the treatment of non-Hodgkin’s lymphoma (NHL), according to a ... global healthcare consulting firm. MabThera is the only biologic ... most common form of NHL. , According to Kantar ... the incidence of NHL in China has been growing ...
(Date:12/22/2014)... Explorys, the leader in big data-driven ... team: Greg Yarrington as Vice President of Operations, Adam ... as Vice President of Solutions. These new leaders are ... in 2015 to support client demand for the company’s ... and growth of its partner network. , Since ...
(Date:12/22/2014)... 2014 In recognition of Veteran’s Day, ... Hero Reward, a local organization that provides services to ... , Located on a couple hundred acres in the ... lodging, world class fishing, hunting, hiking, horseback riding, 4-wheeling, ... several years ago to support U.S. Service men and ...
Breaking Medicine News(10 mins):Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 2Health News:Explorys Continues to Experience Rapid Growth, Adds Three Healthcare IT Executives to Its Leadership Team 3Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2
... is expanding its advanced mobile health screening services ... screening equipment and techniques in the industry, HealthYes! screens its ... aortic aneurysm, peripheral artery disease and osteoporosis. , ... ...
... & Liber LLP have been named 2009 Ohio Super Lawyers ... recognizes the law firm,s expertise in personal injury cases and as ... ... Cleveland, Ohio (PRWEB) March 4, 2009 -- Five Cleveland lawyers representing ...
... cervical cancer may direct more women to optimal ... morbidity and complications of trimodality therapy (surgery followed ... the Institute for Technology Assessment in Boston, MA. ... a decision-analytic model to determine the value of ...
... of trauma patients who undergo CT evaluation have incidental ... Corp. at Grant Medical Center in Columbus, OH. ... concern for physicians in regards to the diagnosis and ... out of 1,256 patients (18.3%) who underwent CT of ...
... York, NY (March 3, 2009) A study published in ... (AJN) found that almost 40% of nurses who were ... of misconduct between 2001 and 2005. Nurses on probation ... to recidivate, suggesting that licensing boards should carefully screen and ...
... published in the Journal of Clinical Endocrinology & ... associate professor of clinical medicine and director of the ... increasingly common with age. An estimated 37 million Americans ... of that population. Another 20 to 30 percent of ...
Cached Medicine News:Health News:HealthYes! Now Offering its Preventive Health Screening Services in Houston 2Health News:HealthYes! Now Offering its Preventive Health Screening Services in Houston 3Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers 2Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers 3Health News:Cleveland Attorneys Recognized as Ohio Super Lawyers 4Health News:MRI and PET/CT improve cervical cancer patient's chances for optimal treatment 2Health News:New research in AJN shows link between nurse's criminal history and professional misconduct 2Health News:New research in AJN shows link between nurse's criminal history and professional misconduct 3Health News:'Pre-diabetics' face heightened risk of heart disease 2
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: